NL-OMON50989招募中4 期
The nephroprotective effect of short hydration during cisplatin treatment in head and neck cancer patients. - Shortcis
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 226
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >=18 years;
- •- Newly diagnosed head and neck cancer with a standard of care indication for
- •cisplatin 40 mg/m2
- •Q1W chemo radiation treatment
- •- Written informed consent according to the International Council for
- •Harmonisation-Good clinical
- •practice (ICH-GCP) and national / local regulations
- •- Ability to return to the Erasmus MC Cancer Institute for adequate follow-up
排除标准
- •- Prior treatment with cisplatin.
- •- The presence of clinically relevant drug interactions according to the
- •current SmPC
- •- The presence of clinically relevant contra-indications according to the
- •current SmPC
- •- Hypersensitivity towards cisplatin or any of the excipients
- •- Pregnancy or lactation
- •- Chronic kidney disease
- •- Baseline eGFR < 60 ml/min
研究者
相似试验
进行中（未招募）
1 期
A study that investigates whether short hydration is a better option to prevent kidney damage than long hydration during cisplatin chemotherapy in patients with head and neck cancer.Cisplatin induced nephrotoxicityEUCTR2020-003890-23-NLErasmus MC Cancer Institute226
尚未招募
4 期
The effect of extra hydration on kidney function during carboplatin-pemetrexed-pembrolizumab in patients with advanced non-small cell lung cancer.;*Hydration to prevent nephrotoxicity due to pemetrexed (HydraPem Study)*kidney injuryNL-OMON52079Erasmus MC, Universitair Medisch Centrum Rotterdam118
尚未招募
不适用
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
已完成
不适用
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30
已完成
不适用
Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period)Chronic renal failure patient with hypertension under going rennin-angiotensin treatment (ARB/ACE-inhibitor) (preservation period)JPRN-UMIN000002478Kure Kyousai Hospital200